Will President Trump’s Executive Order Lower Drug Prices?
Ultimately, assessing the impact of President Trump’s newest iteration of “Most Favored Nation” drug pricing depends on details that have yet to be fleshed out.
Quick Takes - Timely insights and analysis from KFF staff
Filter
-
-
Scaling Back the Nation’s HIV Response? What the Trump Administration’s HHS Budget May Do
Taken together, if approved, these proposed budget cuts and other changes would fundamentally alter the nation’s HIV response which, along with the many other changes being proposed at HHS, does not bode well for making further gains in the fight against HIV.
-
The Rubber is About to Hit the Road on Medicaid Cuts
Once Republicans in Congress get specific about Medicaid cuts, it will become more tangible and clearer who will be affected. Changes to the status quo in health care rarely get more popular when the details get filled in.
-
Final Budget Resolution Codifies Unreconciled Differences on Medicaid Cuts in House and Senate Reconciliation
The budget resolution is unusual because it establishes different tracks for reconciliation in each chamber: House committees are instructed to increase deficits by $2.3 trillion, with major cuts to Medicaid; and Senate committees are instructed to increase deficits by what amounts to $5.8 trillion, without clear implications for Medicaid cuts.
-
Medicare Advantage Payments to Increase Again
The increase translates into an additional $35 billion to Medicare Advantage plans in 2026 compared to this year….The increase in payments is larger than for 2025 (3.7%) or 2024 (3.3%), but below the increase for 2023 (8.5%), and comes at a time of increasing scrutiny over Medicare Advantage payments.
-
President Trump’s Federal Funding Freeze May Reach the Title X Family Planning Program
While [the Title X family planning services] funding freeze could be the Trump administration’s first major salvo in its efforts to weaken and defund Planned Parenthood, more actions...to limit access to abortion and contraception are expected in the coming years.
-
The Next CDC Director Will Face Measles, Bird Flu, and a Skeptical Public
… declining trust in the CDC and in the benefits of childhood vaccinations may complicate any efforts to address emerging public health challenges like the ongoing measles outbreak and the continued threat of bird flu
-
What Does the Trump Administration’s Dismissal of EMTALA Litigation Mean for Emergency Abortion Care?
If the litigation brought by St. Luke’s is not successful, women in six states will continue to be unable to access abortion care in their states when they have a pregnancy-related emergency that puts their health at risk.
-
Cutting HIV Prevention Funding at CDC: What Would it Mean?
Eliminating [HIV prevention funding] could jeopardize recent successes in addressing the nation’s HIV epidemic, including those related to the Ending the HIV Epidemic (EHE) Initiative, which the first Trump administration created
-
The Math is Conclusive: Major Medicaid Cuts Are the Only Way to Meet House Budget Resolution Requirements
The CBO letter confirms early expectations, finding that over the next 10 years, 93% of non-Medicare spending in the E&C [House Energy & Commerce Committee] jurisdiction is from the federal share of Medicaid spending…Even if E&C eliminated all non-Medicaid and CHIP spending, the committee would need to cut federal spending on Medicaid and CHIP by well over $700 billion, nearly 10% of projected spending.
